Study of a new acid reducer for Barrett's esophagus
Part of Cancer, Digestive system clinical trials.
This study tests a new acid-reducing medicine (a potassium-competitive acid blocker) for people with Barrett's esophagus, a condition linked to acid reflux. It aims to see if this new treatment is safe and effective compared to standard proton pump inhibitors, and it might offer a better option for managing the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- Have a diagnosis of Barrett's esophagus without dysplasia.
- Be currently on a proton pump inhibitor (like omeprazole).
- Be able to switch to once-daily dosing if currently on twice-daily.
- Not have any condition that prevents a pH monitoring test (like a recent nose surgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether obeticholic acid (a medicine) can help stop Barrett’s esophagus from getting worse. You must already be taking acid-suppressing medicine and have non-cancer Barrett’s changes, and the study checks safety and whether the lining improves or stays stable.
This study looks at the link between GERD (chronic acid reflux) and Barrett's esophagus, a condition where the lining of the esophagus changes. If you have GERD, joining could help doctors understand who might develop Barrett's and how to catch it early.
This study tests minimally invasive, sample-based tests during an endoscopy to find Barrett’s esophagus and help sort it from esophageal cancer risk. It may help doctors spot changes earlier and more accurately using less invasive methods than standard tissue testing alone.
This study tests a new, less invasive way to detect precancerous changes or early cancer in Barrett's esophagus. It uses a sponge or brush to collect cells from your esophagus during a routine endoscopy, which may help find problems earlier and avoid more invasive procedures.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
This trial compares two ways to choose the best treatment for people with frequent acid reflux. It tests whether using a simple test (called PCAB-guided) is as good as a more detailed test (called physiologic test-guided) for deciding on the right medicine. The goal is to find a more practical and effective approach.
Hear when a new Barrett Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.